Related Experiment Video
Updated: Jan 24, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
Challenges in IBD Research: Precision Medicine.
Lee A Denson1, Mark Curran2, Dermot P B McGovern3
1Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Precision medicine aims to tailor treatments for inflammatory bowel diseases (IBD) by addressing research gaps in predicting disease course and treatment response. This involves developing new molecular technologies and biomarkers for personalized patient care.
Area of Science:
- Gastroenterology and Precision Medicine
Background:
- The Challenges in IBD Research document identifies critical research gaps in inflammatory bowel diseases (IBD).
- Precision medicine is a key focus area, aiming for treatments tailored to individual patient characteristics.
- The document synthesizes multidisciplinary input for patient-centric research prioritization.
Purpose of the Study:
- To highlight key gaps in precision medicine for IBD.
- To outline actionable approaches for advancing IBD precision medicine research.
- To guide research prioritization towards personalized treatments.
Main Methods:
- Identification of main gaps in understanding IBD natural history, predicting disease course/treatment response, and optimizing molecular technologies.
- Proposal of prospective longitudinal cohort studies for biomarker validation.
- Emphasis on harmonization, standardized methods, and advanced technologies like systems biology and machine learning.
Main Results:
- Key research gaps identified in predicting IBD susceptibility, activity, behavior, and treatment response.
- Proposed strategies include longitudinal studies, biomarker discovery, and technological advancements.
- Need for harmonized data and standardized methods across studies.
Conclusions:
- Bridging identified gaps requires robust longitudinal studies and validated precision biomarkers.
- Implementation of advanced molecular and computational technologies is crucial.
- Randomized biomarker-stratified trials are essential to confirm clinical utility and improve patient outcomes.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Uncertainty in Measurement: Accuracy and Precision
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Accuracy and Precision
Microorganisms in Medicine and Therapeutics

